论文部分内容阅读
目的:观察小儿支原体肺炎患者行喜炎平联合阿奇霉素治疗效果,评价药物联合治疗价值。方法:选取本院儿科2015年1月-2015年12月收治的63例小儿支原体肺炎患儿为研究对象,采取随机数字奇偶法分为对照组30例,观察组33例。对照组行阿奇霉素治疗,观察组行喜炎平联合阿奇霉素治疗,对比两组患儿退热时间、咳嗽消失时间、啰音消失时间、住院时间。结果:经治疗两组患儿均较治疗前有明显好转,观察组咳啰音消失时间、住院时间明显短于对照组,差异具有统计学意义(P<0.05);两组患儿退热时间、嗽消失时间数据比较,差异无统计学意义(P>0.05)。结论:喜炎平联合阿奇霉素用于小儿支原体肺炎能显著改善患儿临床症状,缩短啰音消失、住院时间。
Objective: To observe the therapeutic effect of Xiyanping combined with azithromycin in children with mycoplasmal pneumonia and to evaluate the value of drug combination therapy. Methods: A total of 63 children with mycoplasma pneumonia in our hospital from January 2015 to December 2015 were enrolled in this study. They were divided into control group (n = 30) and observation group (n = 33) by random number parity method. The control group was treated with azithromycin. The observation group was treated with Xiyanping combined with azithromycin. The antipyretic time, cough disappearing time, rales disappearing time and hospital stay in both groups were compared. Results: After treatment, the two groups of children were significantly better than before treatment, the observation group cough rales disappear time, hospitalization was significantly shorter than the control group, the difference was statistically significant (P <0.05); two groups of children with antipyretic time , Cough disappear time data, the difference was not statistically significant (P> 0.05). Conclusion: Xiyanping combined with azithromycin in children with mycoplasma pneumonia can significantly improve the clinical symptoms of children, shortening the disappearance of rales, hospitalization time.